File Download
 
Links for fulltext
(May Require Subscription)
  • Find via
 
Supplementary

Conference Paper: Efficacy of telbivudine vs lamivudine at 2 years in patients with hbeag-positive chronic hepatitis B who are eligible for treatment based on guidelines
  • Basic View
  • Metadata View
  • XML View
TitleEfficacy of telbivudine vs lamivudine at 2 years in patients with hbeag-positive chronic hepatitis B who are eligible for treatment based on guidelines
 
AuthorsRasenack, J
Poynard, T
Lai, CL
Gane, E
Brown, NA
Heathcote, J
 
Issue Date2007
 
PublisherElsevier BV. The Journal's web site is located at http://www.elsevier.com/locate/jhep
 
CitationJournal of Hepatology, v. 46 n. Suppl 1, p. S195 [How to Cite?]
 
ISSN0168-8278
2013 Impact Factor: 10.401
 
DC FieldValue
dc.contributor.authorRasenack, J
 
dc.contributor.authorPoynard, T
 
dc.contributor.authorLai, CL
 
dc.contributor.authorGane, E
 
dc.contributor.authorBrown, NA
 
dc.contributor.authorHeathcote, J
 
dc.date.accessioned2010-09-25T20:22:04Z
 
dc.date.available2010-09-25T20:22:04Z
 
dc.date.issued2007
 
dc.identifier.citationJournal of Hepatology, v. 46 n. Suppl 1, p. S195 [How to Cite?]
 
dc.identifier.hkuros152471
 
dc.identifier.issn0168-8278
2013 Impact Factor: 10.401
 
dc.identifier.issueSuppl 1
 
dc.identifier.openurl
 
dc.identifier.spage195
 
dc.identifier.urihttp://hdl.handle.net/10722/102225
 
dc.identifier.volume, v. 46 n. Suppl 1
 
dc.languageeng
 
dc.publisherElsevier BV. The Journal's web site is located at http://www.elsevier.com/locate/jhep
 
dc.relation.ispartofJournal of Hepatology
 
dc.rightsJournal of Hepatology. Copyright © Elsevier BV.
 
dc.titleEfficacy of telbivudine vs lamivudine at 2 years in patients with hbeag-positive chronic hepatitis B who are eligible for treatment based on guidelines
 
dc.typeConference_Paper
 
<?xml encoding="utf-8" version="1.0"?>
<item><contributor.author>Rasenack, J</contributor.author>
<contributor.author>Poynard, T</contributor.author>
<contributor.author>Lai, CL</contributor.author>
<contributor.author>Gane, E</contributor.author>
<contributor.author>Brown, NA</contributor.author>
<contributor.author>Heathcote, J</contributor.author>
<date.accessioned>2010-09-25T20:22:04Z</date.accessioned>
<date.available>2010-09-25T20:22:04Z</date.available>
<date.issued>2007</date.issued>
<identifier.citation>Journal of Hepatology, v. 46 n. Suppl 1, p. S195</identifier.citation>
<identifier.issn>0168-8278</identifier.issn>
<identifier.uri>http://hdl.handle.net/10722/102225</identifier.uri>
<language>eng</language>
<publisher>Elsevier BV. The Journal&apos;s web site is located at http://www.elsevier.com/locate/jhep</publisher>
<relation.ispartof>Journal of Hepatology</relation.ispartof>
<rights>Journal of Hepatology. Copyright &#169; Elsevier BV.</rights>
<title>Efficacy of telbivudine vs lamivudine at 2 years in patients with hbeag-positive chronic hepatitis B who are eligible for treatment based on guidelines</title>
<type>Conference_Paper</type>
<identifier.openurl>http://library.hku.hk:4550/resserv?sid=HKU:IR&amp;issn=0168-8278&amp;volume=46&amp;issue=Suppl 1&amp;spage=S195&amp;epage=&amp;date=2007&amp;atitle=Efficacy+of+telbivudine+vs+lamivudine+at+2+years+in+patients+with+hbeag-positive+chronic+hepatitis+B+who+are+eligible+for+treatment+based+on+guidelines</identifier.openurl>
<identifier.hkuros>152471</identifier.hkuros>
<identifier.volume>, v. 46 n. Suppl 1</identifier.volume>
<identifier.issue>Suppl 1</identifier.issue>
<identifier.spage>195</identifier.spage>
</item>